WordPress database error: [Table './shroom/wp_clean_up_optimizer_ip_locations' is marked as crashed and last (automatic?) repair failed]
SELECT * FROM wp_clean_up_optimizer_ip_locations WHERE ip='3.227.251.94'

WordPress database error: [Table './shroom/wp_clean_up_optimizer_ip_locations' is marked as crashed and last (automatic?) repair failed]
SHOW FULL COLUMNS FROM `wp_clean_up_optimizer_ip_locations`

BetterLife Pharma Inc. – Shroom Investor ๐Ÿ„

BetterLife Pharma Inc.

BetterLife Pharma Inc.

BetterLife Announces Offering of Units

<!-- Name:DistributionId Value:8783646 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 --> <!-- Name:CustomerId Value:1216524 --> <!-- Name:HasMediaSnippet Value:false --> <!-- Name:AnalyticsTrackingId Value:2b7cca25-ad23-435f-b4ab-5d49209e3a38 --> NOT FOR DISTRI... Read More...

BetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Phoenix, Arizona

VANCOUVER, British Columbia, Dec. 02, 2022 -- BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) (CSE: BETR /ย OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, today announced that one of its scientific collaborators, Dr. Argel Aguil... Read More...

BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference

VANCOUVER, British Columbia, June 23, 2022 -- BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) (CSE: BETR /ย OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, today announced that Dr. Ahmad Doroudian, Chief Executive Officer, will p... Read More...

BetterLife’s Wholly-Owned Subsidiary, Altum Pharmaceuticals, Obtains Non-Dilutive Financing Commitment From Strategic Investor!

VANCOUVER, British Columbia, Dec. 22, 2021 -- BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) (CSE:ย BETRย /ย OTCQB:ย BETRFย / FRA: NPAU) today announced that its wholly-owned subsidiary, Altum Pharmaceuticals Inc. (โ€œAltumโ€), has signed an agreement with an European-based investor group to complete a non-brokered financing of up to US$5... Read More...

H.C. Wainwright 2nd Annual Psychedelics Conference, BACK TO THE FUTURE!

VANCOUVER, British Columbia, Dec. 03, 2021 -- BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) (CSE: BETR /ย OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce that Dr. Ahmad Doroudian will be participating in ... Read More...

Developing Psychedelic Medicine Beyond What We Already Know!

VANCOUVER, British Columbia, Nov. 05, 2021 -- BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) (CSE: BETR /ย OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, will participate in a panel discussion at the Microdose Wonderland: Miami... Read More...

BetterLife Announces Exercise of Over-Allotment Option in Public Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 25, 2021 -- BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) (CSE:ย BETRย /ย OTCQB :ย BETRFย / FRA:ย NPAUย ), is pleased to announce the partial exercise of the over-allotment option in conjunction with the Companyโ€™s $2,61... Read More...

BetterLife Pharma Engages Global Financial and Corporate Communications Agency

VANCOUVER, British Columbia, June 22, 2021 -- BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce that it has engaged U.K.-based financial and corporate communications consultancy Buchanan Communications Ltd. (โ€œBuchananโ€).Buchanan, which is base... Read More...

BetterLife Pharma Retains Proactive Investors and Psychedelic Finance for Market Awareness

VANCOUVER, British Columbia, June 10, 2021 -- BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce that it has retained Proactive Investors (โ€œProactiveโ€) and Psychedelic Finance to broaden the Company's reach within a global investor network, as... Read More...

BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada

VANCOUVER, Jan. 18, 2021 -- BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments in mental disorders and viral infections, is pleased to announce that Health Canada has confirmed that 2-bromo-LS... Read More...

BetterLife Provides Shareholder Update and 2021 Product Development Roadmap

VANCOUVER, Jan. 11, 2021 -- VANCOUVER, January 12, 2021 - BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and commercialization of cutting-edge treatments in mental disorders and viral infections, is pleased to provide an overview of the Companyโ€™... Read More...

BetterLife Announces Formation of Next Generation Psychedelic Research Advisory Board

VANCOUVER, Jan. 07, 2021 -- January 7, 2021 - BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce the formation of its Next Generation Psychedelic Research Advisory Board and appointment of highly experienced Ms. Hattie Wells as its first member... Read More...

BetterLife Pharma Strengthens Board of Directors

VANCOUVER, Dec. 28, 2020 -- BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) CSE: BETR / OTCQB: BETRF / FRA: NPAU) an emerging biotech company, is pleased to announce that it has added Mr. Sergei Stetsenko to its Board of Directors to prepare for its growth phase in psychedelic medicines. Mr. Stetsenko is a financier and venture cap... Read More...

BetterLife Welcomes Psychedelic Industry Leaders to the Senior Management Team

VANCOUVER, Dec. 22, 2020 -- BetterLife Pharma Inc. (โ€œBetterLifeโ€ or the โ€œCompanyโ€) CSE: BETR / OTCQB: BETRF / FRA: NPAU) an emerging biotech company, is pleased to announce that Patrick Kroupa and Justin Kirkland, two industry leaders in psychedelic therapeutics, have joined the Company. Mr. Kroupa and Mr. Kirkland will join the senior ma... Read More...